INTRODUCTION
Radiotherapy, chemotherapy and surgical resection including total mesorectal excision (TME) are the standard components of treatment for patients with locally advanced rectal cancer. The optimum sequence has been investigated in randomized trials, and preoperative chemoradiotherapy (CRT) is the preferred treatment for improving local control. A German trial [1] , published in 2004, confirmed that preoperative CRT has significantly lower local failure rates and toxicity rates than postoperative CRT, as well as improved rates of sphincter preservation.
These findings led to a change from postoperative to preoperative CRT; preoperative CRT, TME and adjuvant che- 
OPTIMAL TIME INTERVAL BETWEEN COMPLETION OF CHEMORADIOTHE-RAPY AND SURGERY
Surgery has generally been performed 4 to 8 weeks after conventional CRT is completed. This interval allows the patient to recover from the acute side effects of CRT and adequate time for the tumor to respond to CRT. If the tumor response to CRT is time-dependent, a longer interval between CRT and surgery may result in a better tumor response to CRT, as several retrospective studies have suggested. Tulchinsky et al. [2] reported that patients operated on more than 7 weeks after CRT had a pathologic complete regression (pCR) rate of 35%, compared with 17% for patients operated on less than 7 weeks after CRT (P = 0.03). Kalady et al. [3] reported a 31% pCR rate in patients operated on more than 8 weeks after CRT compared with 16% in patients operated on less than 8 weeks after CRT.
Moore et al. [4] suggested that a longer interval between CRT and surgery was associated with an increased pCR rate (19% pCR rate in patients operated on more than 44 days after CRT, compared with 12% in patients operated on less than 44 days after CRT), but the effect obtained was not statistically significant. However, other studies have observed no difference in pCR rates for longer intervals between CRT and surgery [5, 6] . Recently, the Timing of Rectal Cancer Response to Chemoradiation Consortium reported preliminary results from a prospective, multicenter, phase II clinical trial investigating extending the interval between CRT and surgery [7] . After conventional CRT using 5-Fluorouracil and radiation for 5 to 6 weeks, the patients of study group 1 (SG1, n = 60) underwent TME 6 weeks later, and patients of study group 2 (SG2, n = 67) who showed a clinical response 4 weeks after CRT received two cycles of modified FOLFOX-6 followed by TME 3 to 5 weeks later. The average times between CRT and surgery were 6 weeks (SG1) and 11 weeks (SG2), and the rates of pCR were 18% (SG1) and 25% (SG2, P = 0.0217).
Based on these results, the Consortium suggested that adding chemotherapy after CRT and extending the interval between CRT and surgery increases the pCR rate.
Traditionally, surgeons have been reluctant to postpone surgery for more than 6 to 8 weeks after CRT, because of the concern that postradiotherapy fibrosis may increase the difficulty of the TME and increase the risk of postoperative complications. In addition, a longer interval might allow the tumor to spread, which could ultimately reduce survival rates.
The Timing of Rectal Cancer Response to Chemoradiation Consortium reported more pelvic fibrosis in patients operated on 11 weeks after CRT (score 4.0) than after 6 weeks (score 2.4) (P = 0.0003) [7] . However, the increase in fibrosis did not significantly increase the technical difficulty of the operation (P = 0.2220) and did not increase the risk of postoperative complications [7] . Several previous studies also reported that increasing the interval between the completion of CRT and surgery did not appear to increase postoperative morbidity [2, [4] [5] [6] [8] [9] [10] [11] [12] .
The impact of delaying surgery on the oncological outcome is an important consideration. Few studies have examined long-term data on the interval between CRT and surgery. Glehen et al. [13] reported the long-term results of the Lyons R90-01 trial, which examined outcomes after short (less than 2 weeks) and longer intervals (6 to 8 weeks) after preoperative radiotherapy (RT) (39 Gy in 13 fractions).
The study found similar overall survival (OS) and local recurrence rates for the two groups during a 6.3-year median follow-up period, and suggested that delaying surgery was not detrimental to survival. Consistent with the Lyons trial, several studies [6, 7] reported that a longer interval between preoperative RT or CRT and surgery did not lead to a worse outcome than a shorter interval. In contrast, other groups reported that delayed surgery did have a negative impact on survival. Supiot et al. [14] found that an interval of more than 16 weeks between diagnosis and surgery could reduce OS rates for patients treated with preoperative radiation. They concluded that surgery should be performed shortly after irradiation is completed.
Thus the optimal interval between CRT and surgery re- 
ADEQUATE DISTAL RESECTION AND CIRCUMFERENTIAL RADIAL MARGIN
The DRM affects both local recurrence and the feasibility of sphincter-preserving surgery for rectal cancer.
The current National Comprehensive Cancer Network (NCCN) guidelines recommend a DRM of 4 to 5 cm for an adequate mesorectal excision and 1 to 2 cm for TME in patients with distal (＜5 cm from the anal verge) rectal cancers. They also suggest that the DRM should be confirmed to be tumor-free by frozen section [15] . These suggestions are based on the findings that distal mesorectal spread is limited to 4 to 5 cm from the distal tumor edge [16, 17] , and distal intramural or extrarectal spread, if present, is limited to within 2 cm in 95% of all patients [18, 19] .
The 2 cm rule is supported by several studies on the effect of the DRM on oncological outcomes. Pollett and Nicholls [18] divided 334 rectal cancer patients who underwent curative resection into three groups according to the length of the DRM: ≤2 cm, ＞2 to ＜5 cm, and ≥5 cm.
They found that these three groups had similar results for local recurrence and OS. Although some investigators have suggested a DRM of 1 cm [20] , such a short DRM is not acceptable in locally advanced rectal cancer because the extent of distal spread is associated with a tumor stage [21] .
However, distal tumor spread can be pathologically cleared by preoperative CRT, and a clear DRM of 1 cm has been suggested to be oncologically adequate in patients who receive preoperative CRT [22] . This suggestion is supported by a prospective study by Guillem et al. [23] , who analyzed distal intramural spread in 109 rectal cancer specimens after preoperative CRT and TME by comprehensive whole-mount pathology. Only two specimens (1.8%) had intramural extensions beyond tumor edges measuring less than 0.95 cm. The main problem is that the length of the DRM depends on the measurement method.
The various measurement methods for DRM must be compared to determine an oncologically safe DRM.
The status of the CRM has a substantial impact on local recurrence rates [15, [24] [25] [26] and has been found to be an acceptable surrogate endpoint for local recurrence and disease-free survival (DFS) [27] . NCCN guidelines suggest that a positive CRM is defined as tumor ≤1 mm from the margin [15] and Folkesson et al. [28] reported that the local recurrence rate was 22% when the CRM was involved and 5% when the CRM was not involved ( ＞1 mm).
The CRM issue in rectal cancer is closely associated with the location of the tumor. The risk of an involved CRM is higher for low rectal cancers because the mesorectum tapers as it approaches the levator muscles. ThE Magnetic Resonance Imaging and Rectal Cancer European Equivalence (MERCURY) study [29] reported surgical outcomes in 153 patients with low rectal cancers and found that 31.9% of abdominoperineal resection (APR) specimens had involved CRM, compared with 12% of low anterior resections. They also reported that the quality of the mesorectal specimens was worse in patients undergoing APR (complete TME: 30.6% in APR vs. 75.3% in anterior resection). Therefore, the European Extralevator Abdominoperineal Excision Study Group suggested a wider perineal resection to address the problem of conventional APR and reported the results of 176 patients who had undergone extralevator APR. They confirmed that removing additional tissue reduced CRM involvement (from 49.6% to 20.3%, P ＜ 0.001) [30] .
SPHINCTER PRESERVATION
One aim of preoperative CRT followed by surgical resection is tumor downstaging and reducing tumor volume, which may make sphincter-preserving surgery possible. Two randomized trials [1, 31] There are two meta-analyses to determine whether preoperative radiotherapy improves the outcome for patients with localized resectable rectal cancer. Wong et al. [35] analyzed the results of 19 trials comparing preoperative radiotherapy with surgery alone, and reported that the evidence did not show any sphincter-preserving benefit of combined CRT or selective postoperative radiotherapy.
The pooled odds ratio for preoperative radiotherapy was 0.94 (95% confidence interval, 0.88 to 1.04), which was not statistically significant. However, the data were borderline in homogeneity (P = 0.05), suggesting there were variations in the magnitude of effect across the studies. In a recent review that analyzed 17 randomized trials, the authors concluded that none of the neoadjuvant treatments tested was able to demonstrate an increase in the rate of sphincter-preserving surgery [36] . However, these two meta-analyses did not consider the effect of conservative management (transanal local excision or close observation for good responder to CRT) on the rate of sphincter-preserving surgery. Recently, several clinical trials have found local excision to be a promising surgical treatment after preoperative CRT. If the oncological safety of conservative management after preoperative CRT for low-lying rectal cancer, where conventional APR is inevitable, is established, the benefit of improved sphincter preservation from preoperative CRT should be reevaluated.
LAPAROSCOPIC SURGERY
Laparoscopic procedures for rectal cancer are technically demanding because TME and autonomic nerve preservation are prerequisites for functional and oncological safety. Although the results are still a matter for debate, the use of laparoscopy for rectal cancer has increased because of its short-term feasibility, safety, and oncological evidences [37] [38] [39] [40] [41] [42] [43] . 
CONSERVATIVE MANAGEMENT
Surgical resection of the rectum may be associated with significant morbidity with permanent stoma construction [47] . Furthermore, significant anorectal dysfunction (restricted social lives or deteriorating quality of life) occurs in some rectal cancer patients who have been treated by preoperative RT followed by radical surgery [48] [49] [50] . 
Recently, the American College of Surgeons Oncology
Group has completed the Z6041 phase II trial of patients with clinical T2N0 rectal cancer who received preoperative CRT (total dose 54 Gy) with capecitabine and oxaliplatin followed by transanal local excision 6 weeks after completion of CRT [57] . Of 77 patients who underwent local excision, 34 achieved a pCR (44%), 49 (64%) had ypT0-1, and 4 (5%) had ypT3 tumors. All but one had negative margins. Acute toxicity of at least grade 3 during CRT occurred in 39% of the patients, and rectal pain was the most common postoperative complication. Clearly, longer follow-up is needed to assess the oncologic outcome. After acceptance for oncologic safety of the Z6051 trial, the next step could be phase II nonrandomized trials in patients with cT3 rectal cancer.
ISSUES FOR THE FUTURE
Multimodal treatment for locally advanced rectal cancer patients has evolved, and must be further optimized.
Important issues are testing for response or nonresponse to CRT before administering CRT, and accurate evaluation of tumor responsiveness or nodal involvement in the mesorectum with improved imaging. These clinicopathologic and/or molecular predictors as well as accurate evaluators (imaging or nomograms) should be an integral part of the multimodal treatment of locally advanced rectal cancer.
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